Immediate Impact
2 from Science/Nature 83 standout
Citing Papers
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
Targeting KRAS in cancer
2024 Standout
Works of D. Kim being referenced
P52.03 Efficacy of Sotorasib in KRAS p.G12C-Mutated NSCLC with Stable Brain Metastases: A Post-Hoc Analysis of CodeBreaK 100
2021
MA11.08 Patient-Reported Outcomes from the Randomized Phase 3 CROWN Study of First-Line Lorlatinib versus Crizotinib in ALK+ NSCLC
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| D. Kim | 316 | 269 | 122 | 16 | 339 | |
| J.C.-H. Yang | 277 | 260 | 91 | 12 | 345 | |
| Minal Mehta | 298 | 277 | 90 | 19 | 367 | |
| M.R. García Campelo | 293 | 276 | 114 | 34 | 373 | |
| Mauricio Cuello | 245 | 184 | 97 | 17 | 321 | |
| You Lu | 292 | 239 | 57 | 22 | 321 | |
| Janice J.N. Li | 211 | 171 | 109 | 16 | 317 | |
| Michela Lia | 239 | 142 | 109 | 15 | 314 | |
| Masayuki Yasugi | 236 | 233 | 131 | 22 | 348 | |
| Laura Schubert | 276 | 194 | 195 | 13 | 386 | |
| Graham Cohen | 154 | 199 | 101 | 18 | 303 |
All Works
Loading papers...